-
Sector Analysis
Laryngoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033
Laryngoscopes Market Report Overview The laryngoscopes market size was valued at $341.2 million in 2023 and is forecast to grow at a CAGR of more than 5% during 2023 and 2033. Laryngoscopes are used for viewing the vocal chords, glottis, larynx, to find pre-cancerous lesions and to allow for tracheal intubation. Surgeries that use laryngoscopes include respiratory procedures and laryngectomy procedures. Laryngoscopes Market Outlook, 2023-2033 ($ Million) Buy the Full Report For More Insights Into The Laryngoscopes Market Forecast, Download...
-
Product Insights
Multiparameter Patient Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Multiparameter Patient Monitoring Pipeline Market Report Overview Multiparameter patient monitoring includes devices used for continuous monitoring of physiological and vital parameters such as temperature, blood pressure (BP), oxygen saturation in blood (SpO2), respiration rate (RR), and capnography (CO2) in patients continuously. These types of monitors are used in emergency settings, operation theatres (OT), intensive care units (ICU), and physician’s clinics. The multiparameter patient monitoring pipeline market research report provides comprehensive information about the Multiparameter patient monitoring pipeline products with a...
-
Product Insights
PainChek Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our PainChek Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. PainChek Ltd (PainChek), formerly ePAT Technologies Ltd, is a medical technology company that offers mobile medical applications. It offers mobile applications that offer pain assessment for individuals that are unable to communicate with carers. Its mobile medical application, PainChek, uses the facial recognition software to facilitate and improve pain assessment in patients. The company’s mobile medical applications are combined with...
-
Analyst Opinions
Sustainability in Apparel Industry – Analysing Trends, Opportunities and Strategies for Success
Sustainability in Apparel Industry Report Overview Consumers are increasingly vocal about their desire for more sustainable apparel, but their actions remain constrained by costs. They are becoming increasingly aware of the negative impacts of the fashion industry on the environment. Many brands and retailers are trying to improve their sustainability standards with various initiatives aimed at transitioning towards greater circularity – but most are not yet willing to reduce the number of products they make and sell, which would be...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – oremepermin alfa
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry oremepermin alfa Drug Details Oremepermin alfa (KP-100IT, ChronSeal) is under development for the acute...
-
Product Insights
Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. Symptoms include eye blinking and other eye movements, facial grimacing, shoulder shrugging, and head or shoulder jerking. Other symptoms include touching the nose, smelling objects, flapping the arms, and hopping. The predisposing factors include age. Males are about three to four times more likely than females to develop Tourette syndrome. Treatment includes antidepressants, stimulant medications and behavior therapy. The Tourette syndrome drugs in...
-
Product Insights
Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tourette Syndrome - Drugs in Development, 2021, provides an overview of the Tourette Syndrome (Central Nervous System) pipeline landscape. Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. Symptoms include eye blinking and other eye movements, facial grimacing, shoulder shrugging, and head or shoulder jerking. Other symptoms include touching the nose, smelling objects, flapping the arms and hopping. The predisposing factors include...
-
Product Insights
Ovarian Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Ovarian Cancer Diagnostic Tests include assays of mostly antibodies released in response to a ovarian cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Ovarian Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Ovarian Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Product Insights
Vocal Cord Paralysis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Vocal Cord Paralysis Global Clinical Trials Review, H2, 2018" provides an overview of Vocal Cord Paralysis clinical trials scenario. This report provides top line data relating to the clinical trials on Vocal Cord Paralysis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Canada Neuromodulation Devices Market Outlook to 2025
“What is covered in the report about the “Canada Neuromodulation Devices Market”? GlobalData’s “Canada Neuromodulation Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the Canada Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS). The Canada...